RB
Reborna Biosciences
Reborna Biosciences develops RNA-targeting small molecule drugs aimed at treating genetic diseases caused by RNA mutations. Their research focuses on precise modulation of RNA function to restore normal cellular processes and improve patient outcomes.
- Biotechnology
Updated 23 months ago
Funding
Raised to date
$2.3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Reborna Biosciences develops RNA-targeting small molecule drugs aimed at treating genetic diseases caused by RNA mutations. Their research focuses on precise modulation of RNA function to restore normal cellular processes and improve patient outcomes.